Evaluation of Tocilizumab as corona artery by the European Medicines Agency(EMA)

by in News August 17, 2021

Last Updates Evaluation of Tocilizumab as corona artery by the European Medicines Agency(EMA) Reuters: Europe’s drugs regulator said on Monday it was evaluating the use of Tocilizumab in hospitalised adults with severe COVID-19, its latest review of a potential coronavirus treatment. Tocilizumab has shown promise in clinical trials in treating COVID-19, and was approved by […]

Australian-Iranian SpikoGen Vaccine Clinical Trial

by in News August 15, 2021

Last Updates https://www.aryogen.com/wp/wp-content/uploads/2021/08/SpikoGenStudy.mp4 Australian-Iranian SpikoGen Vaccine Clinical Trial If you would like to participate in a clinical trial of the Australian-Iranian SpikoGen vaccine, you can register via the Spikogen.com website According to the decision of the National Ethics Committee, people aged 50 and over will not be able to participate in the clinical study of […]

CinnaGen Co. pioneers Iran’s pharmaceutical export

by in News August 15, 2021

Last Updates CinnaGen Co. pioneers Iran’s pharmaceutical export IRNA: Dr. Mohammad Reza Monazzam, Manager of Health Technology Development and Industrial Relationship Office, announced that “this is a big honor for country’s high-tech health industries that Cinnagen and Aryogen have been chosen from 1100 assessed companies, and have achieved five-star ranking”. Emphasizing on the fact that this […]

Arylia, AryoGen’s latest product, Denosumab 60 mg effective in controlling and treating various types of osteoporosis

by in News August 15, 2021

Last Updates Arylia, AryoGen’s latest product, Denosumab 60 mg effective in controlling and treating various types of osteoporosis Arylia 60 mg in pre-filled syringe Denosumab 60 mg Therapeutic Indications: treatment of postmenopausal osteoporosis in women and also men who have an increased risk of bone fractures Bone loss that results from a reduction in hormone […]

FDA Authorizes Tocilizumab for Treatment of COVID-19

by in News August 15, 2021

Last Updates FDA Authorizes Tocilizumab for Treatment of COVID-19 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal […]